(Reuters) – Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related flooding.
The North Cove facility, temporarily closed since last month, makes 60% of the nation’s supply of IV fluids and peritoneal dialysis solutions, according to the American Hospital Association.
Its closure had triggered a shortage of IV products, including saline and dialysis solutions, in the U.S.
Baxter has said it targets to return to 90% to 100% allocation of certain IV solutions by the end of 2024.
(Reporting by Sriparna Roy and Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
